Patent ID: 7960362

Claim:
An immune modulatory compound selected from the group consisting of 5′-TCG 1 TACG 1 TACG 1 -X-G 1 CATG 1 CATG 1 CT-5′ [SEQ ID NO.:1], 5′-CAGTCoG 2 TTCAG-X-GACTTG 2 CoTTAC-5′ [SEQ ID NO.:85], 5′-TCG 1 AACG 1 TTCG 1 -L 2 -G 1 CTTG 1 CAAG 1 CT-5′ [SEQ ID NO.:98], 5′-TCG 1 AACG 1 TTCG 1 -Z-G 1 CTTG 1 CAAG i CT-5′ [SEQ ID NO.:113], 5′-TCG 1 AACG 1 TTCG 1 -M-G 1 CTTG 1 CAAG 1 CT-5′ [SEQ ID NO.:114], 5′-TCG 1 AACG 1 TTCG 1 -m-G 1 CTTG 1 CAAG 1 CT-5′ [SEQ ID NO.:115], 5′-TCG 1 AACG 1 TTCG 1 -X 2 -G 1 CTTG 1 CAAG 1 CT-5′ [SEQ ID NO.:116], 5′-TCG 1 AACG 1 TTCG 1 -X 1 -G 1 CTTG 1 CAAG 1 CT-5′ [SEQ ID NO.:117], and 5′-TCG 1 AACG 1 oTTCG 1 -Z-G 1 CTToG 1 CAAG 1 CT-5′ [SEQ ID NO.:153], wherein G 1 =7-deaza-dG; G 2 =AraG; o=phosphodiester linkage; L 2 =tetraethylene glycol linker; M=cis,cis-1,3,5-cyclohexanetriol linker; m=cis,trans-1,3,5-cyclohexanetriol linker; X=glycerol linker; X 1 =1,2,4-butanetriol linker; X 2 =1,3,5-tris(2-hydroxyethyl)cyanuric acid linker; and Z=1,3,5-pentanetriol linker.